Women's Representation in Leadership Positions in Academic Medical Oncology, Radiation Oncology, and Surgical Oncology Programs
- PMID: 32159809
- PMCID: PMC7066474
- DOI: 10.1001/jamanetworkopen.2020.0708
Women's Representation in Leadership Positions in Academic Medical Oncology, Radiation Oncology, and Surgical Oncology Programs
Abstract
Importance: Women are underrepresented in medical leadership positions; however, representation of women among academic oncology leadership is unknown.
Objectives: To evaluate representation of women overall and in leadership positions in academic medical oncology (MO), radiation oncology (RO), and surgical oncology (SO) programs and to examine the association of women leadership with overall faculty representation of women per program.
Design, setting, and participants: In this cross-sectional study, MO, RO, and SO training program websites were queried from October 2018 through June 2019. All faculty from 265 of 273 accredited MO, RO, and SO training programs (97.1%) were included.
Exposure: Gender.
Main outcomes and measures: Observed proportions of women in leadership positions compared with the expected proportion of overall women faculty in MO, RO, and SO were assessed. Rates of representation of women across each MO, RO, and SO program's faculty based on the presence or absence of a woman in a leadership position were compared.
Results: Of 6030 total faculty, only 2164 (35.9%) were women. Total representation of women among MO, RO, and SO faculty was 37.1% (1563 of 4215), 30.7% (389 of 1269), and 38.8% (212 of 546), respectively. Women composed only 21.7% (30 of 138), 11.7% (11 of 94), and 3.8% (1 of 26) of MO, RO, and SO chair positions, respectively. The observed proportion of women in chair positions was significantly lower than the expected proportion for MO, RO, and SO. In all, 47.9%, 33%, and 18.5% of MO, RO, and SO programs, respectively, had at least 1 woman in a leadership position (program director or chair). Programs with 1 or more women in a leadership position were associated with a higher mean (SD) percentage of women faculty than those without at least 1 woman leader in MO (40.7% [12.5%] vs 33.1% [11.0%]; P < .001) and RO (36.2% [13.3%] vs 23.4% [12.3%]; P < .001) but not SO (40.2% [15.4%] vs 31.4% [16.9%]; P = .29).
Conclusions and relevance: Gender disparity exists in academic MO, RO, and SO faculty, which is magnified at the chair level. Programs in MO and RO with a woman physician in a leadership position were associated with a higher percentage of women faculty, but this was not true for SO. These data will serve as a benchmark to monitor progress toward a more balanced workforce.
Conflict of interest statement
Figures
Comment in
-
Ongoing Gender Inequity in Leadership Positions of Academic Oncology Programs: The Broken Pipeline.JAMA Netw Open. 2020 Mar 2;3(3):e200691. doi: 10.1001/jamanetworkopen.2020.0691. JAMA Netw Open. 2020. PMID: 32159807 No abstract available.
Similar articles
-
Diversity Trends by Sex and Underrepresented in Medicine Status Among US Radiation and Medical Oncology Faculty Over 5 Decades.JAMA Oncol. 2022 Feb 1;8(2):221-229. doi: 10.1001/jamaoncol.2021.6011. JAMA Oncol. 2022. PMID: 34882189 Free PMC article.
-
Equity in surgical leadership for women: more work to do.Am J Surg. 2014 Sep;208(3):494-8. doi: 10.1016/j.amjsurg.2013.11.005. Epub 2014 Apr 1. Am J Surg. 2014. PMID: 24933664
-
Addressing Gender Disparity: Increase in Female Leadership Increases Gender Equality in Program Director and Fellow Ranks.Dig Dis Sci. 2022 Feb;67(2):357-363. doi: 10.1007/s10620-020-06686-5. Epub 2021 Jan 6. Dig Dis Sci. 2022. PMID: 33403481
-
An evaluation of programs designed to increase representation of diverse faculty at academic medical centers.J Natl Med Assoc. 2022 Jun;114(3):278-289. doi: 10.1016/j.jnma.2022.01.012. Epub 2022 Mar 2. J Natl Med Assoc. 2022. PMID: 35246333 Review.
-
Diversity in Selected Leadership Positions in United States Academic Pediatric Gastroenterology Programs: A Review and Call to Action.J Pediatr Gastroenterol Nutr. 2022 Feb 1;74(2):244-247. doi: 10.1097/MPG.0000000000003320. J Pediatr Gastroenterol Nutr. 2022. PMID: 34620758 Review.
Cited by
-
Gender profile of principal investigators in a large academic clinical trials group.Front Surg. 2022 Jul 18;9:962120. doi: 10.3389/fsurg.2022.962120. eCollection 2022. Front Surg. 2022. PMID: 35923437 Free PMC article.
-
Tracing ovarian cancer research in Morocco: A bibliometric analysis.Gynecol Oncol Rep. 2021 May 7;37:100777. doi: 10.1016/j.gore.2021.100777. eCollection 2021 Aug. Gynecol Oncol Rep. 2021. PMID: 34150972 Free PMC article.
-
SUPPORT: SUrvey of Parental Leave POlicies of RadiaTion Oncology Programs and Residency Applicants.Adv Radiat Oncol. 2023 Mar 1;8(4):101207. doi: 10.1016/j.adro.2023.101207. eCollection 2023 Jul-Aug. Adv Radiat Oncol. 2023. PMID: 37124316 Free PMC article.
-
Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey.ESMO Open. 2021 Jun;6(3):100131. doi: 10.1016/j.esmoop.2021.100131. Epub 2021 May 25. ESMO Open. 2021. PMID: 34144778 Free PMC article.
-
#JACCCardioOnc: Evolution of a Dedicated Social Media Strategy for JACC: CardioOncology.JACC CardioOncol. 2021 Sep 21;3(3):461-464. doi: 10.1016/j.jaccao.2021.08.004. eCollection 2021 Sep. JACC CardioOncol. 2021. PMID: 34604810 Free PMC article. No abstract available.
References
-
- More women than men enrolled in U.S. medical schools in 2017 [press release]. Washington, DC: Association of American Medical Colleges; December 18, 2017.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials